Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling - Concepedia

Concepedia

Publication | Closed Access

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling

66

Citations

36

References

2022

Year

Ido Yofe, Tomer Landsberger, Adam Yalin, Isabelle Solomon, Cristóbal Costoya, Dafne Franz Demane, Mansi Shah, Eyal David, Chamutal Borenstein, Oren Barboy,

Hematological MalignancyFcγr EngagementCancer ImmunosurveillanceAnti-ctla-4 AntibodiesMyeloid ActivationImmunologyTumor ImmunityImmunotherapyMedicineCell BiologyTumor MicroenvironmentTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1